Skip to content

Application and Evaluation of Vision-LSTM Modeling in Diagnostic Ultrasound Imaging of TI-RADS Category 4b Thyroid Nodules

Application and Evaluation of Vision-LSTM Model in Diagnostic Ultrasound Imaging of TI-RADS Class 4b Thyroid Nodules

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07496684
Enrollment
401
Registered
2026-03-27
Start date
2022-01-01
Completion date
2024-12-30
Last updated
2026-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Cancer

Brief summary

The aim of this study was to evaluate the performance of artificial intelligence (AI) technology in the diagnosis of thyroid nodules, specifically in the field of ultrasound image analysis. It focuses on the accuracy and clinical feasibility of the AI system based on the Vision-LSTM model in the diagnosis of TI-RADS category 4b thyroid nodules.

Interventions

None listed

Sponsors

Ma Zhe
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 78 Years
Healthy volunteers
No

Inclusion criteria

(1) Patients with thyroid nodules visible on ultrasound who underwent biopsy and/or surgical resection. (2) Diagnosed as TI-RADS category 4b on the basis of preoperative ultrasound images by two sonographers with more than 5 years of experience in thyroid ultrasound diagnosis. (3) All nodules underwent puncture biopsy or surgery to obtain pathologic results. \-

Exclusion criteria

(1)The quality of the patient's ultrasound images was poor. (2) The patient has incomplete clinical and imaging data. (3) The patient has had thyroid surgery or other treatment. \-

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of diagnostic modelsImmediately evaluated after the diagnostic model was builtThe study collected ultrasound imaging data from 401 cases of TI-RADS 4b thyroid nodules at our hospital and used this data to train and validate the Vision-LSTM model. The diagnostic results of the AI model were compared with those of junior and senior clinicians to evaluate its performance in terms of diagnostic accuracy and stability; model performance was quantified using metrics such as the area under the curve (AUC) and the precision-recall curve (PR curve).

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 13, 2026